Table 1 Correlation between GAD1 expression and clinical classification in OSCC
Clinical classification | Total | Result of immunostaining | Pvalue | ||
|---|---|---|---|---|---|
No. of patients (%) | |||||
GAD1 (high) | GAD1 (low) | ||||
Age at surgery | |||||
< 60 | 17 | 15 (88%) | 2 (12%) | 0.527 | |
≧ 60 | 63 | 52 (83%) | 11 (17%) | ||
Gender | |||||
Male | 34 | 29 (85%) | 5 (15%) | 0.401 | |
Female | 46 | 38 (83%) | 8 (17%) | ||
T-primary tumor size | |||||
T1 | 8 | 6 (75%) | 2 (25%) | 0.263 | |
T2 | 48 | 38 (79%) | 10 (21%) | ||
T3 | 14 | 13 (93%) | 1 (7%) | ||
T4 | 10 | 10 (100%) | 0 (0%) | ||
N-regional lymph node | |||||
N (negative) | 48 | 36 (75%) | 12 (25%) | 0.011* | |
N (positive) | 32 | 31 (97%) | 1 (3%) | ||
Stage | |||||
I | 8 | 6 (75%) | 2 (25%) | 0.075 | |
II | 40 | 30 (75%) | 10 (25%) | ||
III | 20 | 19 (95%) | 1 (5%) | ||
IV | 12 | 12 (100%) | 0 (0%) | ||
Histopathlogical type | |||||
Well | 54 | 46 (85%) | 8 (15%) | 0.441 | |
Moderately | 16 | 14 (88%) | 2 (12%) | ||
Poorly | 10 | 7 (70%) | 3 (30%) | ||
Tumor site | |||||
Gingiva | 20 | 18 (90%) | 2 (10%) | 0.243 | |
Tongue | 52 | 44 (85%) | 8 (15%) | ||
Buccal mucosa | 4 | 2 (50%) | 2 (50%) | ||
Oral floor | 4 | 3 (75%) | 1 (25%) | ||